Multivalent FZD-Co-Receptor Binders for Selective Wnt Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The hydrophobic nature of Wnt proteins complicates biochemical manipulation, and their cross-reactivity with multiple receptors makes it impossible to selectively activate Frizzled receptor complexes for therapeutic purposes.

Innovation Solution

Development of multivalent binding molecules that bind to both FZD receptors and Wnt co-receptors, using an Fc domain with separate binding domains for each, allowing selective activation of Wnt signaling pathways.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Wnt proteins are used to activate Frizzled receptors, then Wnt signaling pathway activation is achieved, but hydrophobicity and cross-reactivity prevent selective activation and biochemical manipulation

Engineering Contradiction:
Improveselective activation of Frizzled receptor complexesVSAvoidcross-reactivity with multiple receptors
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The multivalent binding molecule is divided into separate functional domains: an Fc domain and distinct binding domains for FZD receptors and Wnt co-receptors. This segmentation allows independent optimization of each binding interface, enabling selective activation of specific Frizzled receptor complexes while avoiding cross-reactivity with other receptors.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The multivalent binding molecule acts as an intermediary that bridges FZD receptors and Wnt co-receptors. Rather than using native Wnt proteins that cross-react with multiple receptors, this engineered molecule selectively mediates the interaction between specific FZD-receptor pairs and their corresponding co-receptors, enabling precise pathway activation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If native Wnt proteins are used, then Wnt signaling is activated, but hydrophobicity complicates biochemical manipulation and purification

Engineering Contradiction:
ImproveWnt signaling pathway activationVSAvoidbiochemical manipulation and purification
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The multivalent binding molecule serves as a soluble, engineered intermediary that replaces native Wnt proteins. It activates Wnt signaling pathways through FZD receptor binding while being inherently water-soluble and genetically encodable, thereby eliminating the hydrophobicity problems associated with native Wnt protein purification and manipulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the chemical parameters of the signaling molecule by replacing hydrophobic native Wnt proteins with hydrophilic, genetically encodable polypeptide-based multivalent binding molecules. This parameter change from hydrophobic to hydrophilic character enables straightforward biochemical manipulation, purification, and storage while maintaining signaling activity.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If multivalent binding molecules are designed with separate binding domains for FZD and co-receptor, then selective activation is achieved, but molecular complexity increases

Engineering Contradiction:
Improveselective Frizzled receptor complex activationVSAvoidmolecule structure with multiple binding domains
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Multiple functional binding domains are merged into a single multivalent binding molecule framework. The Fc domain serves as a central scaffold that combines binding domains for FZD receptors and Wnt co-receptors, creating a unified molecule that simultaneously engages both receptors to activate signaling pathways with high selectivity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The multivalent binding molecule is designed with universal applicability across different FZD receptor types. By using a modular Fc domain framework with interchangeable binding domains, the same basic molecular architecture can selectively activate different Frizzled receptor complexes, providing a universal platform for selective Wnt pathway activation.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260015424A1Multivalent Binding Molecules Activating WNT Signaling and Uses Thereof
Publication Date: 2026.01.15 ANTLERA THERAPEUTICS INC
  • US20260015424A1 patent drawing
  • US20260015424A1 patent drawing
  • US20260015424A1 patent drawing

AI summary

Described herein are methods to affect binding by a multivalent binding molecule to a FZD receptor and a Wnt co-receptor on a cell wherein binding by the multivalent binding molecule to both FZD receptor and co-receptor on the cell activates a Wnt signaling pathway. Also described herein are multivalent binding molecules comprising a FZD receptor binding domain and a Wnt co-receptor biding domain on either end of an Fc domain that activate a Wnt signaling pathway and methods for their use.